Page 4 - செயலில் மருந்து மூலப்பொருள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DRDO s 2DG found effective against all variants of COVID-19: Study

DRDO s 2DG found effective against all variants of COVID-19: Study
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Institute of nuclear medicineNuclear medicineAllied sciencesActive pharmaceutical ingredientDrug licensing authoritiesநிறுவனம் ஆஃப் அணு மருந்துஅணு மருந்துகூட்டணி அறிவியல்செயலில் மருந்து மூலப்பொருள்

UK aid cuts will result in the destruction of millions of doses of life-saving drugs

UK aid cuts will result in the destruction of millions of doses of life-saving drugs
telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomThoko elphick pooleyMichael kremerBoris johnsonWorld health organization in africaDevelopment officeGlobal fund to fightNeglected tropical diseasesWorld health organizationGlobal fundActive pharmaceutical ingredientPrime minister boris johnsonPrime ministerNobel laureate michael kremerஒன்றுபட்டது கிஂக்டம்மைக்கேல் க்ரெமர்

Biophore applies to DCGI for emergency-use approval for COVID treatment drug

NEW DELHI, Jun 11: Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்

Biophore seeks DCGI approval for Aviptadil for Covid treatment

Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.Biophore has .

Andhra pradeshJagadeesh babu rangisettyJagadeesh babuBiophore india pharmaceuticalsHyderabad based biophore india pharmaceuticalsAviptadil inhalationActive pharmaceutical ingredientDrugs controller generalVasoactive intestinal peptideSulfobutyl etherஆந்திரா பிரதேஷ்ஜெகதீஷ் பாபுசெயலில் மருந்து மூலப்பொருள்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

Biophore seeks DCGI emergency use approval for Covid treatment

Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.

Jagadeesh babu rangisettyJagadeesh babuBiophore india pharmaceuticalsAviptadil inhalationActive pharmaceutical ingredientDrugs controller generalVasoactive intestinal peptideSulfobutyl etherCovid 19Nasal spray for covidஜெகதீஷ் பாபுசெயலில் மருந்து மூலப்பொருள்மருந்துகள் கட்டுப்படுத்தி ஜநரல்